The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Integrated Cannabis Company, Inc., d/b/a iCannaCo™, is a global wellness enterprise focused on the development, manufacturing, marketing and distribution of innovative and highly effective botanically-based consumable products.
International Cannabrands Inc. (formerly GEA Technologies Ltd.), licenses the JuJu Royal Ultra Premium Cannabis brand to producers and processors to develop branded strains of cannabis, infused and edible cannabis consumables, as well as ancillary products such as clothing, paraphernalia, posters, and other products. JuJu Royal is a brand created for and inspired by Julian Marley, Reggae Musician and son of the World Renowned Bob Marley. The brand leverages the natural connection between the artist, Julian Marley, reggae music, and cannabis which the Company believes will allow it to capture a significant share of the branded cannabis market.
The total outstanding does not include 1,570,422 of the 1,836,628 Preferred Shares issued that are convertible into 157,042,200 Common Shares, as these Preferred Shares are held by U.S. residents and there are restrictions on the ability to convert depending upon the percentage held by U.S. residents.
The holders of Preferred Shares are entitled to receive notice of and to attend and vote at all meetings of the shareholders of Common Shares and each Preferred shareholders shall have the right to one vote for each Common Share into which such Preferred Share could then be converted (one hundred (100) Common Shares) in person or by proxy at all meetings of the shareholders of the Company. Please see Section 10 Description of the Securities in the Form 2A Listing Statement.
The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.
The Company is engaged in the business of producing nutritional beverage drinks using a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.
Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.
Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in the United States.
Liberty Leaf Holdings Ltd. is a new, Canadian-based, public company whose objective is to be at the forefront of the medicinal and recreational cannabis industry...accelerating revenue-generating businesses within this dynamic and fast-growing sector.
Lifestyle Delivery Systems Inc.’s filmstrip technologies produce an oral delivery system that can be used for energy elixirs, herbal remedies and a smokeless alternative option to medical and recreational users of cannabis. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. The Company will license the technology to licensees, who will in turn manufacture the strips where the legal use of marijuana is allowed.